| DNA-PKcs-mediated transcriptional regulation drives prostate cancer progression and metastasis JF Goodwin, V Kothari, JM Drake, S Zhao, E Dylgjeri, JL Dean, ... Cancer cell 28 (1), 97-113, 2015 | 177 | 2015 |
| A uroguanylin-GUCY2C endocrine axis regulates feeding in mice MA Valentino, JE Lin, AE Snook, P Li, GW Kim, G Marszalowicz, ... The Journal of clinical investigation 121 (9), 2011 | 169 | 2011 |
| Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment CS Hayes, AC Shicora, MP Keough, AE Snook, MR Burns, SK Gilmour Cancer immunology research 2 (3), 274-285, 2014 | 155 | 2014 |
| Non-thermal plasma induces immunogenic cell death in vivo in murine CT26 colorectal tumors AG Lin, B Xiang, DJ Merlino, TR Baybutt, J Sahu, A Fridman, AE Snook, ... Oncoimmunology 7 (9), e1484978, 2018 | 150 | 2018 |
| Colorectal cancer immunotherapy B Xiang, AE Snook, MS Magee, SA Waldman Discovery medicine 15 (84), 301, 2013 | 140 | 2013 |
| The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling JE Lin, P Li, AE Snook, S Schulz, A Dasgupta, TM Hyslop, AV Gibbons, ... Gastroenterology 138 (1), 241-254, 2010 | 129 | 2010 |
| Human GUCY2C-targeted chimeric antigen receptor (CAR)-expressing T cells eliminate colorectal cancer metastases MS Magee, TS Abraham, TR Baybutt, JC Flickinger Jr, NA Ridge, ... Cancer immunology research 6 (5), 509-516, 2018 | 122* | 2018 |
| Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer MS Magee, A Snook Discovery Medicine 18 (100), 265-271, 2014 | 110 | 2014 |
| Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress JC Flickinger Jr, U Rodeck, AE Snook Vaccines 6 (3), 48, 2018 | 107 | 2018 |
| GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity JE Lin, AE Snook, P Li, BA Stoecker, GW Kim, MS Magee, AVM Garcia, ... PloS one 7 (2), e31686, 2012 | 100 | 2012 |
| Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics JE Lin, M Valentino, G Marszalowicz, MS Magee, P Li, AE Snook, ... Toxins 2 (8), 2028-2054, 2010 | 91 | 2010 |
| RB loss promotes prostate cancer metastasis C Thangavel, E Boopathi, Y Liu, A Haber, A Ertel, A Bhardwaj, S Addya, ... Cancer research 77 (4), 982-995, 2017 | 88 | 2017 |
| Non-thermal plasma-induced immunogenic cell death in cancer M Khalili, L Daniels, A Lin, FC Krebs, AE Snook, S Bekeschus, WB Bowne, ... Journal of physics D: Applied physics 52 (42), 423001, 2019 | 73 | 2019 |
| GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity MS Magee, CL Kraft, TS Abraham, TR Baybutt, GP Marszalowicz, P Li, ... Oncoimmunology 5 (10), e1227897, 2016 | 72 | 2016 |
| Obesity-induced colorectal cancer is driven by caloric silencing of the guanylin–GUCY2C paracrine signaling axis JE Lin, F Colon-Gonzalez, E Blomain, GW Kim, A Aing, B Stoecker, ... Cancer research 76 (2), 339-346, 2016 | 67 | 2016 |
| The paracrine hormone hypothesis of colorectal cancer GM Pitari, P Li, JE Lin, D Zuzga, AV Gibbons, AE Snook, S Schulz, ... Clinical Pharmacology & Therapeutics 82 (4), 441-447, 2007 | 67 | 2007 |
| Talkin’toxins: from Coley’s to modern cancer immunotherapy RD Carlson, JC Flickinger Jr, AE Snook Toxins 12 (4), 241, 2020 | 65 | 2020 |
| Functional macroautophagy induction by influenza A virus without a contribution to major histocompatibility complex class II-restricted presentation JD Comber, TM Robinson, NA Siciliano, AE Snook, LC Eisenlohr Journal of virology 85 (13), 6453-6463, 2011 | 65 | 2011 |
| Guanylyl cyclase C–induced immunotherapeutic responses opposing tumor metastases without autoimmunity AE Snook, BJ Stafford, P Li, G Tan, L Huang, R Birbe, S Schulz, ... JNCI: Journal of the National Cancer Institute 100 (13), 950-961, 2008 | 63 | 2008 |
| The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer C Wilson, JE Lin, P Li, AE Snook, J Gong, T Sato, C Liu, MA Girondo, ... Cancer Epidemiology, Biomarkers & Prevention 23 (11), 2328-2337, 2014 | 62 | 2014 |
Scott WaldmanDepartment of Pharmacology & Experimental Therapeutics, Thomas Jefferson UniversityVerified email at jefferson.edu
